| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0081 | 0.9 |